USE OF OKT3 AND ANTI-TAC MONOCLONAL-ANTIBODIES FOR THE QUANTITATIVE ASSAY OF INTERLEUKIN-2

被引:0
|
作者
CORNAGLIAFERRARIS, P
BAFFICO, M
机构
来源
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:471 / 474
页数:4
相关论文
共 50 条
  • [21] SEQUENTIAL ADMINISTRATION OF OKT3 (ANTI-CD3) AND INTERLEUKIN-2 IN 2 PATIENTS WITH CHEMORESISTANT HEMATOLOGICAL DISEASE
    MASSAIA, M
    BIANCHI, A
    PEOLA, S
    BORRIONE, P
    ATTISANO, C
    PILERI, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (03) : 150 - 152
  • [22] BLOCKADE OF THE INTERLEUKIN-2 RECEPTOR BY ANTI-TAC ANTIBODY - INHIBITION OF HUMAN-LYMPHOCYTE ACTIVATION
    DEPPER, JM
    LEONARD, WJ
    ROBB, RJ
    WALDMANN, TA
    GREENE, WC
    JOURNAL OF IMMUNOLOGY, 1983, 131 (02): : 690 - 696
  • [23] PREPARATION AND ANALYSIS OF BIFUNCTIONAL IMMUNOCONJUGATES CONTAINING MONOCLONAL-ANTIBODIES OKT3 AND BABR1
    FOGLESONG, PD
    WINKLER, MA
    PRICE, JO
    MARSHALL, GD
    REAGH, SH
    BUSH, DA
    HIXSON, KS
    WEST, WH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (03) : 177 - 184
  • [24] PLASMA-EXCHANGE (PE) AND MONOCLONAL-ANTIBODIES (OKT3) IN THE TREATMENT OF ACUTE VASCULAR REJECTION
    PRADOS, MC
    FRANCO, A
    PERDIGUERO, MP
    CONTRERAS, J
    OLIVARES, J
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1416 - 1416
  • [25] INTERLEUKIN-2 RECEPTOR BLOCKADE BY ANTI-TAC ANTIBODY INHIBITS IFN-GAMMA INDUCTION
    CROLL, AD
    WILKINSON, MF
    MORRIS, AG
    CELLULAR IMMUNOLOGY, 1985, 92 (01) : 184 - 189
  • [26] NEUTRALIZING MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT HUMAN INTERLEUKIN-2
    IDE, M
    KANEDA, K
    KOIZUMI, K
    HOJO, K
    MURAI, Y
    SAGAWA, K
    KONO, M
    SATO, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 101 (01) : 57 - 62
  • [27] DISSECTION OF THE ROLE OF MACROPHAGES IN TRIGGERING LYMPHOCYTES-T FOR INTERLEUKIN-2 PRODUCTION BY MONOCLONAL-ANTIBODY OKT3
    FUJIMOTO, K
    YAMAMOTO, Y
    OHMURA, T
    KAWAKAMI, K
    ONOUE, K
    MICROBIOLOGY AND IMMUNOLOGY, 1986, 30 (06) : 561 - 572
  • [28] USE OF MONOCLONAL-ANTIBODIES TO T-CELLS (OKT3) FOR TREATMENT OF ACUTE CELLULAR REJECTION AFTER RENAL-TRANSPLANTATION
    BIRKELAND, SA
    SVENDSEN, V
    ROHR, N
    HANSEN, BL
    ELBIRK, A
    FOGED, N
    KOHLER, F
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) : 451 - 454
  • [29] ANTI-IDIOTYPE ANTIBODIES IN PATIENTS TREATED WITH MURINE MONOCLONAL-ANTIBODY, OKT3
    COLVIN, RB
    COSIMI, AB
    BURTON, RC
    KURNICK, JT
    STRUZZIERO, C
    GOLDSTEIN, G
    RUSSELL, PS
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 363 - 363
  • [30] USE OF INTERLEUKIN-2 IN HUMAN CANCER - INVITRO AND INVIVO STUDIES AND POTENTIAL FOR AUGMENTATION WITH MONOCLONAL-ANTIBODIES
    DALGLEISH, AC
    MALKOVSKY, M
    BELLO, C
    SONDEL, P
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 529 - 529